Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

COX-2-derived prostacyclin modulates vascular remodeling.

R Daniel Rudic1, Derek Brinster, Yan Cheng

  • 1The Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia 19104, USA.

Circulation Research
|May 21, 2005
PubMed
Summary

Selective COX-2 inhibitors reduce prostacyclin (PGI2), increasing vascular hyperplasia and reducing blood flow. This suggests a link between COX-2 inhibition and cardiovascular risk during prolonged use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endovascular arch repair using a novel single branch arch stent graft: 30-Day results from the chronic dissection arm of the NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness investigational device exemption study.

JTCVS structural and endovascular·2026
Same author

Hemodynamic principles of arterial cannulation: Orientation, wall shear stress, turbulence, plaque destabilization, and cerebral microembolization.

Asian cardiovascular & thoracic annals·2026
Same author

Quantifying sleep wake rhythms in the hospital environment with digital technologies.

NPJ digital medicine·2026
Same author

Comparing the quantitation of specialized pro-resolving mediators in plasma and serum using ELISA and LC-MS/MS.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same author

TracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes.

medRxiv : the preprint server for health sciences·2026
Same author

Depression of tryptophan may contribute to adverse effects of naproxen.

Nature communications·2026

Area of Science:

  • Vascular Biology
  • Cardiovascular Pharmacology
  • Inflammation Research

Background:

  • Cyclooxygenase-2 (COX-2) inhibitors have been linked to increased myocardial infarction and stroke.
  • Prostacyclin (PGI2) biosynthesis suppression is a potential mechanism for these adverse cardiovascular events.

Purpose of the Study:

  • To investigate the role of COX-2-derived PGI2 in vascular remodeling under physiological stress.
  • To determine the impact of PGI2 suppression on vascular responses to hemodynamic challenges.

Main Methods:

  • Utilized mouse models of transplant arteriosclerosis and flow-induced vascular remodeling.
  • Employed selective COX-2 inhibition (nimesulide) and genetic deletion of the PGI2 receptor (IP).
  • Assessed intimal hyperplasia, luminal geometry, and blood flow changes following carotid artery ligation.

Related Experiment Videos

Main Results:

  • Suppression of PGI2 (via nimesulide or IP deletion) augmented intimal hyperplasia and reduced blood flow.
  • Thromboxane A2 (TxA2) and isoprostane production increased with flow reduction and PGI2 suppression.
  • Thromboxane A2 receptor (TP) deletion mitigated the hyperplastic response to nimesulide and ligation.

Conclusions:

  • COX-2-derived PGI2 plays a critical role in modulating vascular architectural responses to hemodynamic stress.
  • PGI2 suppression significantly influences vascular remodeling, potentially contributing to cardiovascular risk with selective COX-2 inhibitor use.
  • Interactions between vascular remodeling, hypertension, and atherosclerosis may be exacerbated by long-term COX-2 inhibitor therapy.